Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
Recruiting now
Conditions studied: Rheumatoid Arthritis, Interstitial Lung Disease
In brief
The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g. clinical features, genetic variants, and/or biologic markers) between other forms of ILD (e.g. idiopathic pulmonary fibrosis, IPF) and subclinical RA-ILD that places individuals at risk for the development of lung disease.
Key facts
- Study ID
- NCT03297775
- Run by
- University of Colorado, Denver
- People needed
- 750
- Starts
- 2017-06-22
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-05-01
Who can join
Age: 45 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥ 45years old
- Diagnosis of RA using the 2010 American College of Rheumatology (ACR) criteria
You may not qualify if…
- Inability to give informed consent
- Pregnant women
- History of interstitial lung disease
- Evidence of other causes of diffuse parenchymal lung disease such as infection, drug toxicity, other autoimmune processes, etc.
- Subjects over the age of 90 years old or less than 45 years old
Where it is running
- University of Colorado - Anschutz Medical Campus — Aurora, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.